Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 671-684, November 2009

Chromomycin A3 staining, sperm chromatin structure assay and hyaluronic acid binding assay as predictors for assisted reproductive outcome

  • Martine Nijs

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
    • Corresponding Author InformationCorrespondence:
  • ,
  • Eva Creemers

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Annemie Cox

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Kim Franssen

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Mia Janssen

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Elke Vanheusden

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Christopher De Jonge

      Affiliations

    • Reproductive Medicine Centre (RMC), University of Minnesota, Minneapolis, MN, USA
  • ,
  • Willem Ombelet

      Affiliations

    • Genk Institute for Fertility Technology (GIFT), Ziekenhuis Oost Limburg, Genk, Belgium

Received 24 March 2009; received in revised form 14 April 2009; accepted 21 July 2009. published online 02 August 2010.

Declaration: Sources of support – The HBA binding slides for this study were provided by MidAtlantic Diagnostics, Marlton, USA. The authors report no financial or commercial conflicts of interest.

Abstract 

Functional sperm tests such as the sperm chromatin structure assay (SCSA), chromomycin A3 staining (CMA3) and hyaluronic acid binding assay (HBA) have been suggested as predictive tests of fertility in vitro. This study aimed to define the clinical role of these functional parameters in assisted reproduction in a prospective cohort study. Conventional sperm diagnosis (motility, morphology and concentration) as well as SCSA, CMA3 and HBA tests were performed on 205 semen samples [74 IVF, 94 ICSI and 37 combined IVF/intracytoplasmic sperm injection (ICSI)]. Main outcome parameters were fertilization rate, clinical pregnancy rate and take-home baby rate. The study showed that each of the three functional sperm tests was related to one or more conventional and one or more functional sperm tests, indicating that spermatozoa from patients with abnormal conventional semen parameters have a higher likelihood for multiple functional abnormalities. Only SCSA and CMA3 staining were shown to have a limited predictive value when IVF or combined IVF/ICSI was applied. The proposed threshold value of 15% for predicting good fertilization rates and obtaining a pregnancy in IVF could only be confirmed for percent HDS (high DNA stainability in SCSA). ICSI outcome was not influenced by any of the conventional or functional sperm parameters.

Keywords: CMA3, DNA fragmentation, IVF/ICSI outcome, SCSA, sperm morphology, sperm quality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Martine Nijs obtained her PhD in Medical Sciences at the Free University of Brussels in Belgium. She is ESHRE accredited senior clinical embryologist. At present, she is the director of the IVF laboratory at the Genk Institute for Fertility Technology in Genk, Belgium. Her main interests are sperm quality, sperm freezing and human embryology. Dr Martine Nijs

 Partially presented as an oral communication (0–165) at the 21st Meeting of ESHRE, Copenhagen, Denmark, 19–22, June 2005.Partially presented as a poster at the 31st Annual Meeting of the American Society of Andrology, Chicago, USA, April 8–11, 2006.Partially presented as a poster at the Satellite Sperm DNA workshop in Rome, 11–13 March, 2009.

PII: S1472-6483(09)00064-9

doi:10.1016/j.rbmo.2009.07.002

Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 671-684, November 2009